Previous dramatic reduction of HbA1c and retinopathy in Type 2 Diabetes

Yau, 2012, Global prevalence and major risk factors of diabetic retinopathy, Diabetes Care, 35, 556, 10.2337/dc11-1909 Estacio, 1998, Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM, Am J Kidney Dis, 31, 947, 10.1053/ajkd.1998.v31.pm9631838 Leske, 2005, Schachat AP; Barbados Eye Study Group. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies, Ophthalmology., 112, 799, 10.1016/j.ophtha.2004.11.054 Chew, 2014, The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, Ophthalmology., 121, 2443, 10.1016/j.ophtha.2014.07.019 Zhang, 2015, Liu H Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials, Endocrine., 49, 78, 10.1007/s12020-014-0459-8 Solomon, 2017, Diabetic retinopathy: a position statement by the American Diabetes Association, Diabetes Care, 40, 412, 10.2337/dc16-2641 Feldman-Billard, 2018, Massin P; Standards for screening and surveillance of ocular complications in people with diabetes SFD study group. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes, Diabetes Metab, 44, 4, 10.1016/j.diabet.2017.10.014 Hooymans, 1982, Worsening of diabetic retinopathy with strict control of blood sugar, Lancet., 2, 438, 10.1016/S0140-6736(82)90464-0 Chew, 1995, Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study, Diabetes Care, 18, 631, 10.2337/diacare.18.5.631 Gibbons, 2010, Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy, Ann Neurol, 67, 534, 10.1002/ana.21952 DCCT Group, 1998, Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial, Arch Ophthalmol, 116, 874, 10.1001/archopht.116.7.874 Cheung, 2015, The impact of bariatric surgery on diabetic retinopathy: a systematic review and meta-analysis, Obes Surg, 25, 1604, 10.1007/s11695-014-1539-9 Shurter, 2013, Ipp E Euglycemic progression: worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities, Diabetes Res Clin Pract, 100, 362, 10.1016/j.diabres.2013.03.018 Marso, 2016, Semaglutide and cardiovascular outcomes in patients with type 2 diabetes, N Engl J Med, 375, 1834, 10.1056/NEJMoa1607141 Vilsbøll, 2018, Simó R, et al Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy, Diabetes Obes Metab, 20, 889, 10.1111/dom.13172 Dormandy, 2005, PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial, Lancet., 366, 1279, 10.1016/S0140-6736(05)67528-9 Dargie, 2007, A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure, J Am Coll Cardiol, 49, 1696, 10.1016/j.jacc.2006.10.077 Kooy, 2009, Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus, Arch Intern Med, 169, 616, 10.1001/archinternmed.2009.20 Marso, 2016, Liraglutide and cardiovascular outcomes in type 2 diabetes, N Engl J Med., 375, 311, 10.1056/NEJMoa1603827 Zinman, 2015, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes, N Engl J Med, 373, 2117, 10.1056/NEJMoa1504720 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet., 352, 837, 10.1016/S0140-6736(98)07019-6 Action to Control Cardiovascular Risk in Diabetes Study Group, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med., 358, 2545, 10.1056/NEJMoa0802743 Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, 358, 2560, 10.1056/NEJMoa0802987 Bain, 2018, Worsening diabetic retinopathy with rapid improvement in systemic glucose control: a review, Diabetes Obes Metab Jingi, 2017, Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis, BMC Endocr Disord, 17, 63, 10.1186/s12902-017-0213-3 Brynskov, 2016, Thickening of inner retinal layers in the parafovea after bariatric surgery in patients with type 2 diabetes, Acta Ophthalmol, 94, 668, 10.1111/aos.13087 Casson, 2004, Hypoglycaemia exacerbates ischaemic retinal injury in rats, Br J Ophthalmol, 88, 816, 10.1136/bjo.2003.024661 Cougnard-Gregoire, 2020, Trends in the use of eye care services in adults treated for diabetes between 2008 and 2017 in France: a nationwide study, Ophthalmic Res, 10.1159/000506136 Dahl-Jørgensen, 1985, Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study, Br Med J (Clin Res Ed), 290, 811, 10.1136/bmj.290.6471.811 Henricsson, 1997, The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus, Diabet Med, 14, 123, 10.1002/(SICI)1096-9136(199702)14:2<123::AID-DIA306>3.0.CO;2-U Ismail-Beigi, 2010, Cohen RM, et al effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomized trial, Lancet., 376, 419, 10.1016/S0140-6736(10)60576-4 Gerstein, 2013, Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial, Diabetes Care, 36, 1266, 10.2337/dc12-1311 Roysarkar, 1993, Effect of insulin therapy on progression of retinopathy in non-insulin-dependent diabetes mellitus, Am J Ophthalmol, 115, 569, 10.1016/S0002-9394(14)71452-7 Arun, 2004, Long-term progression of retinopathy after initiation of insulin therapy in type 2 diabetes; an observational study, Diabetologia, 47, 1380, 10.1007/s00125-004-1473-9 Sander, 2013, Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes, Diabetologia, 56, 2359, 10.1007/s00125-013-3027-5